| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study
|
Dy, G.K.
|
|
|
16 |
11 |
p. 1811-1816
|
artikel
|
| 2 |
Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study
|
Freyer, G.
|
|
|
16 |
11 |
p. 1795-1800
|
artikel
|
| 3 |
Continued gefitinib treatment after disease stabilisation prolongs survival of Japanese patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience
|
Hotta, K.
|
|
|
16 |
11 |
p. 1817-1823
|
artikel
|
| 4 |
Definition of disease-free survival: this is my truth–show me yours
|
Chua, Y.J.
|
|
|
16 |
11 |
p. 1719-1721
|
artikel
|
| 5 |
Does an apple a day keep the oncologist away?
|
Gallus, S.
|
|
|
16 |
11 |
p. 1841-1844
|
artikel
|
| 6 |
Endocrine pancreatic tumors: factors correlated with survival
|
Tomassetti, P.
|
|
|
16 |
11 |
p. 1806-1810
|
artikel
|
| 7 |
Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer
|
Huang, H.J.
|
|
|
16 |
11 |
p. 1755-1761
|
artikel
|
| 8 |
Increased risk of esophageal cancer after breast cancer
|
Levi, F.
|
|
|
16 |
11 |
p. 1829-1831
|
artikel
|
| 9 |
In this issue
|
|
|
|
16 |
11 |
p. 1717
|
artikel
|
| 10 |
Introducing the BECT (biologically enhanced cytotoxic treatment) concept in cancer treatment
|
Bernier, J.
|
|
|
16 |
11 |
p. 1722
|
artikel
|
| 11 |
Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy
|
Burstein, H.J.
|
|
|
16 |
11 |
p. 1772-1777
|
artikel
|
| 12 |
Limitations of molecular detection of CK19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically negative axillary lymph nodes
|
Pitini, V.
|
|
|
16 |
11 |
p. 1845
|
artikel
|
| 13 |
Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome
|
Romanini, A.
|
|
|
16 |
11 |
p. 1832-1840
|
artikel
|
| 14 |
Neoadjuvant chemotherapy with infusional 5-fluorouracil, adriamycin and cyclophosphamide (iFAC) in locally advanced breast cancer: an early response predicts good prognosis
|
Moon, Y.W.
|
|
|
16 |
11 |
p. 1778-1785
|
artikel
|
| 15 |
Non-enrolment of ovarian cancer patients in clinical trials: reasons and background
|
Harter, P.
|
|
|
16 |
11 |
p. 1801-1805
|
artikel
|
| 16 |
Novel targeted therapies in the treatment of gastric and esophageal cancer
|
Tabernero, J.
|
|
|
16 |
11 |
p. 1740-1748
|
artikel
|
| 17 |
Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?
|
Duric, V.M.
|
|
|
16 |
11 |
p. 1786-1794
|
artikel
|
| 18 |
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group
|
Fountzilas, G.
|
|
|
16 |
11 |
p. 1762-1771
|
artikel
|
| 19 |
Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma
|
Moulopoulos, L.A.
|
|
|
16 |
11 |
p. 1824-1828
|
artikel
|
| 20 |
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
|
Colozza, M.
|
|
|
16 |
11 |
p. 1723-1739
|
artikel
|
| 21 |
Pulmonary hypertension related to thalidomide therapy in refractory multiple myeloma
|
Antonioli, E.
|
|
|
16 |
11 |
p. 1849-1850
|
artikel
|
| 22 |
Reply to the Letter to the Editor “Limitations of molecular detection of CK19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically negative axillary lymph nodes” by V. Pitini et al. (Ann Oncol 2005; 16: 1845)
|
Stathopoulos, E.
|
|
|
16 |
11 |
p. 1845-1846
|
artikel
|
| 23 |
Somatic mutation of EGFR catalytic domain and treatment with gefitinib in colorectal cancer
|
Moroni, M.
|
|
|
16 |
11 |
p. 1848-1849
|
artikel
|
| 24 |
Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases
|
Albiges, L.
|
|
|
16 |
11 |
p. 1846-1847
|
artikel
|
| 25 |
Stereotactic radiosurgery for brain oligometastases: good for some, better for all?
|
Gupta, T.
|
|
|
16 |
11 |
p. 1749-1754
|
artikel
|
| 26 |
Table of Contents
|
|
|
|
16 |
11 |
p. i-ii
|
artikel
|
| 27 |
Vascular endothelial growth factor (VEGF) expression is not associated with prognosis in patients with radically resected ampullary carcinoma
|
Santini, D.
|
|
|
16 |
11 |
p. 1847-1848
|
artikel
|
Tijdschrift beschrijving